Iobenguane

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 42 Experts worldwide ranked by ideXlab platform

Hein J Verberne - One of the best experts on this subject based on the ideXlab platform.

  • proposal for standardization of 123i metaiodobenzylguanidine mibg cardiac sympathetic imaging by the eanm cardiovascular committee and the european council of nuclear cardiology
    European Journal of Nuclear Medicine and Molecular Imaging, 2010
    Co-Authors: Albert Flotats, Ignasi Carrio, Denis Agostini, Dominique Le Guludec, Claudio Marcassa, Michael Schaffers, Aernout G Somsen, Mustafa Unlu, Hein J Verberne
    Abstract:

    This proposal for standardization of 123I-metaiodobenzylguanidine (Iobenguane, MIBG) cardiac sympathetic imaging includes recommendations for patient information and preparation, radiopharmaceutical, injected activities and dosimetry, image acquisition, quality control, reconstruction methods, attenuation, scatter and collimator response compensation, data analysis and interpretation, reports, and image display. The recommendations are based on evidence coming from original or scientific studies whenever possible and as far as possible reflect the current state-of-the-art in cardiac MIBG imaging. The recommendations are designed to assist in the practice of performing, interpreting and reporting cardiac sympathetic imaging. The proposed standardization does not include clinical indications, benefits or drawbacks of cardiac sympathetic imaging, and does not address cost benefits or cost effectiveness; however, clinical settings of potential utility are mentioned. Standardization of MIBG cardiac sympathetic imaging should contribute to increasing its clinical applicability and integration into current nuclear cardiology practice.

Albert Flotats - One of the best experts on this subject based on the ideXlab platform.

  • proposal for standardization of 123i metaiodobenzylguanidine mibg cardiac sympathetic imaging by the eanm cardiovascular committee and the european council of nuclear cardiology
    European Journal of Nuclear Medicine and Molecular Imaging, 2010
    Co-Authors: Albert Flotats, Ignasi Carrio, Denis Agostini, Dominique Le Guludec, Claudio Marcassa, Michael Schaffers, Aernout G Somsen, Mustafa Unlu, Hein J Verberne
    Abstract:

    This proposal for standardization of 123I-metaiodobenzylguanidine (Iobenguane, MIBG) cardiac sympathetic imaging includes recommendations for patient information and preparation, radiopharmaceutical, injected activities and dosimetry, image acquisition, quality control, reconstruction methods, attenuation, scatter and collimator response compensation, data analysis and interpretation, reports, and image display. The recommendations are based on evidence coming from original or scientific studies whenever possible and as far as possible reflect the current state-of-the-art in cardiac MIBG imaging. The recommendations are designed to assist in the practice of performing, interpreting and reporting cardiac sympathetic imaging. The proposed standardization does not include clinical indications, benefits or drawbacks of cardiac sympathetic imaging, and does not address cost benefits or cost effectiveness; however, clinical settings of potential utility are mentioned. Standardization of MIBG cardiac sympathetic imaging should contribute to increasing its clinical applicability and integration into current nuclear cardiology practice.

Rachel R Phillips - One of the best experts on this subject based on the ideXlab platform.

  • anatomic and functional imaging of metastatic carcinoid tumors
    Radiographics, 2007
    Co-Authors: A F Scarsbrook, Arul Ganeshan, Jane Statham, Rajesh V Thakker, Andrew Weaver, Denis C Talbot, Philip Boardman, Kevin M Bradley, Fergus V Gleeson, Rachel R Phillips
    Abstract:

    Carcinoid tumors are a fascinating group of neuroendocrine neoplasms that develop either sporadically or as part of an inheritable syndrome. Many tumors arise in the bronchopulmonary or gastrointestinal tract, but a neuroendocrine tumor can arise in almost any organ. The tumors have varied malignant potential depending on the site of their origin, and the clinical manifestations often are nonspecific. Metastases may be present at the time of diagnosis, which often occurs at a late stage of the disease. Imaging plays a pivotal role in the localization and staging of neuroendocrine tumors and in monitoring the treatment response. Imaging is often challenging, and a combination of anatomic and functional techniques is usually required, depending on the tumor type and location. Techniques include ultrasonography, barium studies, endoscopy, computed tomography, magnetic resonance imaging, somatostatin receptor scintigraphy, Iobenguane scintigraphy, and, in select cases, positron emission tomography. Coregistra...

A F Scarsbrook - One of the best experts on this subject based on the ideXlab platform.

  • anatomic and functional imaging of metastatic carcinoid tumors
    Radiographics, 2007
    Co-Authors: A F Scarsbrook, Arul Ganeshan, Jane Statham, Rajesh V Thakker, Andrew Weaver, Denis C Talbot, Philip Boardman, Kevin M Bradley, Fergus V Gleeson, Rachel R Phillips
    Abstract:

    Carcinoid tumors are a fascinating group of neuroendocrine neoplasms that develop either sporadically or as part of an inheritable syndrome. Many tumors arise in the bronchopulmonary or gastrointestinal tract, but a neuroendocrine tumor can arise in almost any organ. The tumors have varied malignant potential depending on the site of their origin, and the clinical manifestations often are nonspecific. Metastases may be present at the time of diagnosis, which often occurs at a late stage of the disease. Imaging plays a pivotal role in the localization and staging of neuroendocrine tumors and in monitoring the treatment response. Imaging is often challenging, and a combination of anatomic and functional techniques is usually required, depending on the tumor type and location. Techniques include ultrasonography, barium studies, endoscopy, computed tomography, magnetic resonance imaging, somatostatin receptor scintigraphy, Iobenguane scintigraphy, and, in select cases, positron emission tomography. Coregistra...

  • Anatomic and functional imaging of metastatic carcinoid tumors
    'Radiological Society of North America (RSNA)', 2007
    Co-Authors: A F Scarsbrook, Ganeshan A, Statham J, Rv Thakker, Weaver A, Talbot D, Boardman P, Km Bradley, Fv Gleeson, Rr Phillips
    Abstract:

    Carcinoid tumors are a fascinating group of neuroendocrine neoplasms that develop either sporadically or as part of an inheritable syndrome. Many tumors arise in the bronchopulmonary or gastrointestinal tract, but a neuroendocrine tumor can arise in almost any organ. The tumors have varied malignant potential depending on the site of their origin, and the clinical manifestations often are nonspecific. Metastases may be present at the time of diagnosis, which often occurs at a late stage of the disease. Imaging plays a pivotal role in the localization and staging of neuroendocrine tumors and in monitoring the treatment response. Imaging is often challenging, and a combination of anatomic and functional techniques is usually required, depending on the tumor type and location. Techniques include ultrasonography, barium studies, endoscopy, computed tomography, magnetic resonance imaging, somatostatin receptor scintigraphy, Iobenguane scintigraphy, and, in select cases, positron emission tomography. Coregistration of structural and functional images is often of incremental value for accurate localization of the primary tumor and any meta-static disease. Radiologists must understand the contribution of each imaging modality in the assessment of different neuroendocrine tumors. In addition, knowledge of the optimal technique for each radiologic and radionuclide imaging examination is essential. Familiarity with the protean imaging appearances of both primary and metastatic disease is essential for accurate staging, treatment monitoring, and surveillance. Finally, an understanding of the wide variety of treatment options for patients with carcinoid tumors is vital for optimal management

Mustafa Unlu - One of the best experts on this subject based on the ideXlab platform.

  • proposal for standardization of 123i metaiodobenzylguanidine mibg cardiac sympathetic imaging by the eanm cardiovascular committee and the european council of nuclear cardiology
    European Journal of Nuclear Medicine and Molecular Imaging, 2010
    Co-Authors: Albert Flotats, Ignasi Carrio, Denis Agostini, Dominique Le Guludec, Claudio Marcassa, Michael Schaffers, Aernout G Somsen, Mustafa Unlu, Hein J Verberne
    Abstract:

    This proposal for standardization of 123I-metaiodobenzylguanidine (Iobenguane, MIBG) cardiac sympathetic imaging includes recommendations for patient information and preparation, radiopharmaceutical, injected activities and dosimetry, image acquisition, quality control, reconstruction methods, attenuation, scatter and collimator response compensation, data analysis and interpretation, reports, and image display. The recommendations are based on evidence coming from original or scientific studies whenever possible and as far as possible reflect the current state-of-the-art in cardiac MIBG imaging. The recommendations are designed to assist in the practice of performing, interpreting and reporting cardiac sympathetic imaging. The proposed standardization does not include clinical indications, benefits or drawbacks of cardiac sympathetic imaging, and does not address cost benefits or cost effectiveness; however, clinical settings of potential utility are mentioned. Standardization of MIBG cardiac sympathetic imaging should contribute to increasing its clinical applicability and integration into current nuclear cardiology practice.